Abstract
Ebola viruses (family: Filoviridae) are the cause of Ebola virus disease (EVD), a highly fatal illness characterised by haemorrhagic fever syndrome in both humans and non-human primates (NHPs). West Africa was the epicentre of the 2013–2015 EVD epidemic which caused the death of over 11,000 people, including eight casualties in southern Nigeria. Antibodies to filoviruses have been detected among NHPs in some countries, but there is no documented evidence of exposures to filoviruses among NHPs in Nigeria. From August 2015 to February 2017, a total of 142 serum samples were obtained from individual captive and wild animals, belonging to 11 NHP species, in southern Nigeria, and screened for species-specific antibodies to filoviruses belonging to the species; Zaire ebolavirus [Ebola virus (EBOV)], Sudan ebolavirus [Sudan virus (SUDV)], and Marburg marburgvirus [Ravn virus (RAVV)]–using a modifed filovirus species-specific ELISA technique. Of the sera tested, 2.1% (3/142) were positive for antibodies to EBOV. The entire 142 sera were negative for SUDV or RAVV. These findings point to the existence of natural exposures of NHPs in southern Nigeria to EBOV. There is need to discourage, the uncontrolled hunting of NHPs in Nigeria for public health safety.
Article PDF
Avoid common mistakes on your manuscript.
References
World Health Organization. Statement on the 1st meeting of the IHR emergency committee on the 2014 Ebola outbreak in West Africa. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/; 2014 [accessed 15.09.17].
Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Barister JR, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol 2013;158;301–11.
Centers for Disease Control. About Ebola hemorrhagic fever. http://www.cdc.gov/vhf/ebola/about.html, [accessed 23.08.17].
Rajak H, Jain DK, Singh A, Sharma AK, Dixit A. Ebola virus disease: past, present and future. Asi-Pac J Trop Biomed 2015;5;337–43.
Changula K, Kajihara M, Mweene AS, Takada A. Ebola and Marburg virus diseases in Africa. Increased risk of outbreaks in previously unaffected areas? Microbiol Immunol 2014;58; 483–91.
Olugasa BO, Oshinowo OY, Odigie EA. Preventive and social cost implications of Ebola Virus Disease (EVD) outbreak on selected organizations in Lagos state, Nigeria. Pan Afr Med J 2015;22;20.
Centers for Disease Control. Cost of the Ebola Epidemic. http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/cost-of-ebola.html, [accessed 23.08.17].
Mohammed H, Vandy AO, Stretch R, Otieno D, Prajapati M, Calderon M, et al. Sequelae and other conditions in Ebola virus disease survivours, Sierra Leone, 2015. Emerg Infect Dis 2017;23;66–73.
Shuaib F, Gunnala R, Musa EO, Mahoney FJ, Oguntimehin O, Nguku PM, et al. Centers for Disease Control and prevention (CDC). Ebola virus disease outbreak - Nigeria, July-September 2014. Morbidity Mortal Weekly Report (MMWR) 2014;63;867–72.
Tomori O. Will Africa’s future epidemic ride on forgotten lessons from the Ebola epidemic? BioMed Central Med 2015;13;116.
Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 1988;38;407–10.
Formella M, Gatherer D. The serology of ebolavirus – a wider geographical range, a wider genus of viruses or a wider range of virulence? J Gen Virol 2016;97;3120–30.
Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, Froment JM, et al. A serological survey of Ebola virus infection in central African nonhuman primates. J Infect Dis 2004;190;1895–9.
Hayman DTS, Yu M, Crameri G, Wang L-F, Suu-Ire R, Wood JLN, et al. Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerg Infect Dis 2012;18;1207–9.
Saéz AM, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Düx A, et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med 2015;7;17–23.
Hopkins ME, Nunn CL. A global gap analysis of infectious agents in wild primates. Divers Distrib 2007;13;561–72.
Ksiazek JG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999;179;S192–S8.
Broadhurst MJ, Brooks TJ, Pollock NR. Diagnosis of Ebola virus disease: past, present, and future. Clin Microbiol Rev 2016;29;773–93.
Prehaud C, Hellebrand E, Coudrier D, Volchkov VE, Volchkova VA, Feldmann H, et al. Recombinant Ebola Virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infection. J Gen Virol 1998;79;2565–72.
Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, Matsuno K, et al. Enzyme-linked immunosorbent assay for detection of Filovirus species-specific antibodies. Clin Vaccine Immunol 2010;17;1723–8.
MacNeil A, Reed Z, Rollin PE. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis 2011;5;e1175.
Wang B, Kluwe CA, Lungu OI, DeKosky DJ, Kerr SA, Johnson EL, et al. Facile discovery of a diverse panel of anti-Ebola virus antibodies by immune repertoire mining. Sci Rep 2015;5;13926.
Pickering BS, Collignon B, Smith G, Marszal P, Kobinger G, Weingartl HM. Detection of Ebola Zaire ebolavirus in swine: assay development and optimisation. Transboundary Emerg Dis 2018;65;77–84.
Nigeria National Park Service. Cross River national park. http//:www.nigeriaparkservice.org/?p=140 [accessed 16.09.17].
Wolfe ND, Daszak P, Kilpatrick AM, Burke DS. Bushmeat hunting and deforestation in prediction of zoonoses emergence. Emerg Infect Dis 2005;11;1822–7.
Friant S, Paige SB, Goldberg TL. Drivers of bushmeat hunting and perceptions of zoonoses in Nigerian hunting communities. PloS Negl Trop Dis 2015;9;e0003792.
Ogunro B, Olugasa B, Olaleru F, Oladiti F. Human – monkey interaction on a university campus in Nigeria: an avenue for zoonotic disease transmission at the human wildlife interface? Sokoto J Vet Sci 2017;15;54–61.
O’Hearn AE, Voorhees MA, Fetterer DP, Wauquier N, Coomber MR, Bangura J, et al. Serosurveillance of viral pathogens circulating in West Africa. Virol J 2016;13;163. Published online: 3 October 2016.
Bower H, Glynn JR. A systematic review and meta- analysis of seroprevalence surveys of ebolavirus infection. Sci Data 2017. Published online: 31 January 2017.
Becker S, Becker S, Feldmann H, Will C, Slenczka W. Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? Med Microbiol Immunol 1992;181;43–55.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article under the CC BY-NC license (http://creativecommons.org/licences/by-nc/4.0/).
About this article
Cite this article
Ogunro, B.N., Olugasa, B.O., Verschoor, E.J. et al. Serological Detection of Ebola Virus Exposures in Native Non-human Primates of Southern Nigeria. J Epidemiol Glob Health 8, 162–170 (2018). https://doi.org/10.2991/j.jegh.2018.05.001
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/j.jegh.2018.05.001